Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): An Eastern cooperative oncology group study
1989 ◽
Vol 17
(3)
◽
pp. 197-201
◽